.avif)
Acute Kidney Injury
Acute Kidney Injury develops quickly, disrupting filtration, fluid balance, and toxin clearance. Biomarker testing confirms stress and function changes early. At Superpower, we measure creatinine, estimated glomerular filtration rate (eGFR), blood urea nitrogen (BUN), and the BUN/creatinine ratio to detect and stage AKI and monitor recovery.
Chronic Kidney Disease
Biomarker testing detects early Chronic Kidney Disease by tracking filtration, protein balance, and mineral regulation. At Superpower, we measure Creatinine, eGFR, BUN, Albumin, Corrected Calcium, and Potassium to assess glomerular function, nitrogen waste clearance, oncotic pressure, and electrolyte–bone homeostasis, revealing kidney reserve and systemic impact.
Hypercalcemia
Hypercalcemia signals disrupted calcium homeostasis across parathyroid, bone, kidney, and gut. Accurate assessment requires total calcium adjusted for protein binding. At Superpower, we test for Calcium, Corrected Calcium, and Albumin for Hypercalcemia to reveal true calcium status, guide differential causes, and monitor system stress affecting mineral balance and neuromuscular function.
Hyperkalemia
Hyperkalemia can silently destabilize heart rhythm and neuromuscular function by raising extracellular potassium, altering membrane excitability (serum K+). Biomarker testing detects imbalance early and signals kidney and endocrine system stress. At Superpower, we test for Potassium for Hyperkalemia to monitor electrolyte homeostasis and protect cardiovascular stability.
Hypernatremia
Hypernatremia signals disrupted water balance and cellular dehydration, reflecting kidney function and neuroendocrine control (ADH, plasma osmolality). Measuring serum sodium pinpoints severity and cause. At Superpower, we test for Sodium for Hypernatremia to gauge its impact on brain, cardiovascular, and renal systems.
Hypocalcemia
Hypocalcemia can disturb nerve, muscle, and heart function, and signal bone-mineral or hormone imbalances. Accurate assessment requires measuring blood calcium and adjusting for protein levels. At Superpower, we test Calcium, Corrected Calcium (albumin-adjusted), and Albumin to reveal true calcium status and the underlying calcium–parathyroid–vitamin D system health.
Hypokalemia
Hypokalemia—low blood potassium—disrupts nerve signaling, muscle contraction, and heart rhythm. Biomarker testing identifies deficits before complications. At Superpower, we test serum Potassium for Hypokalemia, revealing electrolyte balance, kidney handling, and hormonal effects, enabling accurate interpretation of neuromuscular and cardiovascular status.
Hyponatremia
Hyponatremia signals disrupted water–salt balance, affecting nerve and muscle function and brain health. Measuring serum sodium quantifies osmolar status and guides understanding of volume regulation (ADH/renal handling). At Superpower, we test for Sodium for Hyponatremia to detect dilutional states, endocrine causes, and renal sodium loss early.
Nephrotic Syndrome
Nephrotic syndrome reflects a leaky kidney filter causing protein loss and compensatory lipid rises. Biomarker testing clarifies protein status and atherogenic burden. At Superpower, we test for Albumin, Total Protein, LDL, Triglycerides, and ApoB to track hypoalbuminemia, protein depletion, and dyslipidemia, anchoring diagnosis and ongoing system-health monitoring.
Osteomalacia
Osteomalacia reflects impaired bone mineralization from disrupted vitamin D–calcium balance. Biomarker testing clarifies mineral metabolism and bone turnover. Vitamin D (25‑OH), serum calcium, and alkaline phosphatase track deficiency and osteoid remodeling. At Superpower, we test for Vitamin D, Calcium, and ALP for osteomalacia.
Osteoporosis
Osteoporosis begins with silent shifts in bone remodeling. Biomarker testing reveals mineral homeostasis underlying skeletal strength. At Superpower, we measure Vitamin D, Calcium, Albumin, and Corrected Calcium to assess calcium availability (bioavailability) and bone turnover physiology early, guiding risk stratification and monitoring.
SIADH
Biomarker testing helps confirm SIADH by revealing disordered water balance and dilutional hyponatremia. Sodium tracks true hyponatremia; albumin helps interpret volume status and oncotic pressure that can mimic or modify findings. At Superpower, we test for Sodium, Albumin for SIADH.
